Maria Cecilia Hospital
| Italia | Turchia | Austria | |
| Resezione dell'intestino tenue | da $18,000 | da $12,150 | da $25,000 |
| Radioterapia per il cancro intestinale | da $9,800 | da $5,800 | da $6,853 |
| Radioterapia per il cancro colorettale | da $7,000 | da $7,000 | da $12,000 |
| Chemioterapia per carcinoma mammario | da $4,500 | da $1,200 | da $15,000 |
| Chemioterapia Intraperitoneale Ipertermica (HIPEC) | da $25,000 | da $22,500 | da $40,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro dell'intestino tenue. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro dell'intestino tenue e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro dell'intestino tenue.
Dr. Antonio Braun has performed over 12,000 gastrointestinal interventions at Maria Cecilia Hospital. He is a board-certified general surgeon specializing in bariatric and digestive surgery. He completed a two-year training internship at Johns Hopkins University. Dr. Braun uses laparoscopic techniques to improve patient recovery and safety.
Dr. Marcello Deraco has treated over 1,200 patients with peritoneal cancer. He directs the Peritoneal Surface Malignancies Unit at Maria Cecilia Hospital. Dr. Deraco specializes in cytoreductive surgery and heated chemotherapy. He is a professor of surgery at Milan University.
Il medico è un oncologo medico esperto con oltre 30 anni di pratica, specializzato in adenocarcinoma pancreatico, tumori gastro-esofagei e tumori del sistema nervoso centrale. Il medico è Direttore del Programma Strategico di Coordinamento Clinico presso il Centro Pancreas dell'IRCCS Ospedale San Raffaele dal 2016.<\/p>
Il medico ha coordinato le linee guida dell'Associazione Italiana di Oncologia Medica per il trattamento e la gestione del cancro al pancreas. Con un forte background accademico dall'Università di Milano, il medico possiede specializzazioni in oncologia radioterapica e clinica. Il medico ha pubblicato oltre 180 articoli e ha presieduto numerosi studi clinici sul cancro pancreatico metastatico.<\/p>
Dr. Pasquale Totaro is a reproductive endocrinologist at Ospedale Santa Maria in Bari. He coordinates a fertility center performing 1,000+ procedures every year. Under his leadership, the hospital ranks first in Italy for intrauterine insemination (IUI) cycles. Dr. Totaro specializes in medically assisted procreation and obstetrics-gynecological ultrasound.
Top Italian hospitals for small intestine cancer focus on high-volume oncology centers known as Scientific Institutes for Research, Hospitalization, and Healthcare (IRCCS). These facilities utilize multidisciplinary teams and specialized protocols like Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or minimally invasive resections to treat rare gastrointestinal malignancies.
Bookimed Expert Insight: Italian surgical expertise in this field is remarkably deep. Dr. Antonio Braun has performed over 12,000 gastrointestinal interventions. Meanwhile, Prof. Marcello Deraco has successfully treated over 1,200 patients with advanced peritoneal cases. When choosing a facility, look for these individual high-volume surgical records. This level of experience often leads to more precise outcomes in rare cancer cases.
Patient Consensus: Patients emphasize choosing major university hospitals where pathology re-review is available. They note that having rapid imaging and surgery planning in one system is vital for rare cancers.
Primary surgical options in Italy focus on radical resection to achieve R0 margins. Surgeons perform segmental resections for jejunal tumors or complex pancreaticoduodenectomy for duodenal lesions. Advanced cases may receive cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Procedures follow strict European Society for Medical Oncology protocols.
Bookimed Expert Insight: While many patients focus only on the surgery type, centralized expertise in Italy often hinges on specific unit directors. For instance, Dr. Antonio Braun at Maria Cecilia Hospital has performed over 12,000 gastrointestinal procedures. Choosing a surgeon with such high volume in laparoscopic techniques can significantly shorten your recovery time. Furthermore, Professor Marcello Deraco has treated over 1,200 patients using hyperthermic intraperitoneal chemotherapy. His experience is vital for complex cases where cancer has reached the abdominal lining.
Patient Consensus: Patients emphasize the need to confirm if a laparoscopic approach is possible to speed up healing. They often suggest bringing detailed pathology reports because surgical plans change drastically between GIST and adenocarcinoma treatments.
Multidisciplinary teams (GOM) are actively available in Italy for rare gastrointestinal cancers like small intestine malignancies. These specialized oncology groups consolidate surgical, radiological, and pathological expertise. This centralized approach ensures precise diagnostics and advanced surgical options like cytoreductive surgery and HIPEC for complex cases.
Bookimed Expert Insight: While many Italian facilities offer oncology services, peak expertise for rare small bowel tumors is often concentrated in clinics with dedicated Peritoneal Surface Malignancy units. Professor Marcello Deraco at Maria Cecilia Hospital has performed over 1,200 specialized procedures. Choosing a center with this level of high-volume surgical experience is vital for managing rare digestive tract malignancies effectively.
Patient Consensus: Patients emphasize that for rare cancers, the most critical step is confirming that a team of specialists reviews the case together. Many advise seeking second opinions at large academic hospitals to ensure the most modern pathology review and surgical coordination.
Italy serves as a European hub for treating Stage 4 peritoneal metastases. Clinics offer advanced locoregional therapies like cytoreductive surgery and heated chemotherapy. These specialized treatments target cancer within the abdominal cavity directly. Italy maintains a standardized oncology network to ensure high-volume surgical expertise.
Bookimed Expert Insight: Italian expertise in peritoneal surface malignancies is highly concentrated in specific surgical teams. Professor Marcello Deraco at Maria Cecilia Hospital has treated over 1,200 patients using CRS and HIPEC. This volume is critical because high-experience surgeons often achieve better outcomes in complex gastrointestinal cases. Patients should prioritize specialists with at least 500 completed procedures for these aggressive abdominal interventions.
Patient Consensus: Patients emphasize that eligibility depends heavily on a low tumor burden score. They recommend seeking second opinions from specialized centers to confirm if complete tumor removal is possible.
Patients in Italy enroll in experimental clinical trials for rare tumors through specialized oncology networks. The Associazione Italiana di Oncologia Medica (AIOM) portal provides a central database for research studies. Enrollment requires a referral from an oncologist at a recognized Italian reference center.
Bookimed Expert Insight: Data shows that choosing specialists with research leadership roles significantly speeds up trial access. Professor Michele Reni at San Raffaele Milan coordinates national oncology guidelines and chairs clinical trials. Similarly, Professor Marcello Deraco at Maria Cecilia Hospital leads specialized units for peritoneal malignancies. These doctors often have first-hand knowledge of investigator-driven studies before they appear in public databases.
Patient Consensus: Patients note that preparing translated pathology slides and treatment history early prevents screening delays. They emphasize asking about molecularly matched or basket trials instead of just looking for stage-specific studies.
International patients can travel to Italy for treatment by securing a medical visa and hospital declaration. EU citizens enjoy visa-free entry, while non-EU patients require a Type C or D visa. You must provide proof of payment and sufficient funds for housing and medical expenses.
Bookimed Expert Insight: Italian gastrointestinal specialists demonstrate exceptionally high surgical volumes that correlate with procedure safety. Dr. Antonio Braun at Maria Cecilia Hospital has performed over 12,000 gastrointestinal interventions. Prof. Marcello Deraco has treated 1,200+ patients using advanced intraperitoneal chemotherapy. Choosing such high-volume experts is vital for rare conditions like small intestine cancer.
Patient Consensus: Patients note that medical travel is most effective when seeking second opinions or rare tumor experts. It is essential to have all pathology reports and scans ready before starting the process.